Trials / Completed
CompletedNCT04012047
Headache Inducing Effect of Levcromakalim in Migraine With Aura Patients
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 17 (actual)
- Sponsor
- Danish Headache Center · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
To investigate the role of KATP channels in migraine with aura patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Levcromakalim | To investigate the role of levcromakalim compared with placebo in migraine with aura patients |
| DRUG | Saline | To investigate the role of levcromakalim compared with placebo in migraine with aura patients |
Timeline
- Start date
- 2019-07-09
- Primary completion
- 2019-12-10
- Completion
- 2019-12-10
- First posted
- 2019-07-09
- Last updated
- 2020-03-02
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT04012047. Inclusion in this directory is not an endorsement.